Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...

Former Colorado football quarterback Shedeur Sanders has taken a tumble in the 2025 NFL Draft on Thursday, as he has yet to be drafted after the Pittsburgh Steelers' No. 21 overall pick.

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

Private businesses that give away all profits and also succeed as businesses are scarce; An eleemosynary aim would seem to be ...